File(s) under permanent embargo
Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease
journal contributionposted on 2023-05-18, 14:26 authored by Venigalla, M, Sonego, S, Gyengesi, E, Matthew SharmanMatthew Sharman, Munch, G
Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized by deposition of amyloid plaques and neurofibrillary tangles, as well as microglial and astroglial activation, and, finally, leading to neuronal dysfunction and death. Current treatments for AD primarily focus on enhancement of cholinergic transmission. However, these treatments are only symptomatic, and no disease-modifying drug is available for the treatment of AD patients. This review will provide an overview of the antioxidant, anti-inflammatory, anti-amyloidogenic, neuroprotective, and cognition-enhancing effects of a variety of nutraceuticals including curcumin, apigenin, docosahexaenoic acid, epigallocatechin gallate, α-lipoic acid and resveratrol and their potential for AD prevention and treatment. We suggest that therapeutic use of these compounds might lead to a safe strategy to delay the onset of AD or slow down its progression. The continuing investigation of the potential of these substances is necessary as they are promising compounds to yield a possible remedy for this pervasive disease.
Publication titleNeurochemistry International
Department/SchoolSchool of Health Sciences
PublisherPergamon-Elsevier Science Ltd
Place of publicationUnited Kingdom
Rights statementCopyright 2015 Elsevier Ltd.